Share Issuance and Financing Through the Exercise of Stock Acquisition Rights
First written in FY2018-Q2. 12 of 14 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2026-H1.
103 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note) 2 5,400 3,504,100 3,154 983,911 3,154 65,834」
During the interim period, 5,400 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥3,154 thousand. Cash flow statements also recorded ¥4,040 thousand in proceeds from the issuance of shares upon the exercise of stock acquisition rights. - FY2025AdvancedAnnual report
「1 April 2024–31 March 2025 Change in total number of shares issued 7,000 Change in stated capital ¥1,923 thousand Change in capital surplus ¥1,923 thousand (Note) Due to the exercise of stock acquisition rights.」
During the fiscal year, 7,000 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥1,923 thousand. - FY2023AdvancedAnnual report
「1 April 2022–31 March 2023 (Note) 1 7,600 3,235,000 2,003 932,627 2,003 14,549」
7,600 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥2,003 thousand. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 4,800 3,235,000 1,130 932,627 1,130 14,549 (Note) Increase due to the exercise of stock acquisition rights.」
From July to September 2022, 4,800 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥1,130 thousand. - FY2023-Q1AdvancedAnnual report
「1 April 2022–30 June 2022 (Note) 2,800 3,230,200 872 931,496 872 13,419 (Note) Increase due to the exercise of stock acquisition rights.」
In the first quarter, 2,800 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥872 thousand. - FY2020AdvancedAnnual report
「Net cash provided by financing activities was ¥543 thousand. This was due to increases including ¥595 thousand in proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
During the fiscal year, 1,100 shares were issued upon the exercise of stock acquisition rights, raising ¥595 thousand. - FY2020-Q2AdvancedAnnual report
「Net cash provided by financing activities was ¥543 thousand (compared with ¥6,145 thousand provided in the same quarter of the previous year). This was mainly due to ¥595 thousand in proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
During the cumulative second-quarter period, ¥595 thousand was raised through the exercise of stock acquisition rights. From July to September 2019, 500 shares were issued, increasing both stated capital and capital surplus by ¥213 thousand. - FY2020-Q1AdvancedAnnual report
「1 April 2019–30 June 2019 600 3,226,500 255 930,284 255 12,206 (Note) 1. Increase due to the exercise of stock acquisition rights.」
In the first quarter, 600 shares were issued upon the exercise of stock acquisition rights, increasing both stated capital and capital surplus by ¥255 thousand. - FY2019RestatedAnnual report
「Funds provided by financing activities amounted to ¥6.145 million. This represented an increase in funds from proceeds of ¥1.219 million from the issuance of shares through the exercise of stock acquisition rights and ¥4.926 million from the issuance of stock acquisition rights.」
The company continues to raise funds through the issuance and exercise of stock acquisition rights. - FY2019-Q2AdvancedAnnual report
「Funds provided by financing activities amounted to ¥6.145 million, compared with ¥6.629 million in the same quarter of the previous year. This comprised proceeds of ¥4.926 million from the issuance of stock acquisition rights and ¥1.219 million from the issuance of shares through the exercise of stock acquisition rights.」
The company raised ¥4.926 million through the issuance of stock acquisition rights and ¥1.219 million through the issuance of shares upon their exercise, thereby advancing financing through financing activities during the cumulative period. - FY2019-Q1AdvancedAnnual report
「1 April 2018 to 30 June 2018 Change in total number of issued shares 1,600 Change in share capital ¥1.090 million Change in capital surplus ¥1.090 million (Note) The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the company issued 1,600 shares through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥1.090 million each. - FY2018AdvancedAnnual report
「Funds provided by financing activities amounted to ¥12.936 million. This represented an increase in funds from proceeds of ¥12.936 million from the issuance of shares through the exercise of stock acquisition rights.」
The company raised ¥12.936 million during the current consolidated fiscal year through the exercise of stock acquisition rights, increasing the number of issued shares by 13,500. - FY2018-Q3AdvancedAnnual report
「1 October 2017 to 31 December 2017 Change in total number of issued shares 5,400 Change in share capital ¥4.863 million Change in capital surplus ¥4.863 million (Note) The increase resulted from the exercise of stock acquisition rights.」
During the third quarter, the company issued 5,400 shares through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥4.863 million each. - FY2018-Q2First statedAnnual report
「Funds provided by financing activities amounted to ¥6.629 million, compared with none in the same quarter of the previous year. This represented proceeds of ¥6.629 million from the issuance of shares through the exercise of stock acquisition rights.」
During the cumulative second quarter, the company raised ¥6.629 million through the issuance of shares upon the exercise of stock acquisition rights, increasing the total number of issued shares by 7,700. In addition, 2,700 shares were issued between 1 October 2017 and 31 October 2017, increasing share capital and the capital surplus by ¥2.408 million each.